Original Research
Published on 21 May 2025
CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
in Multiple Sclerosis and Neuroimmunology
- 452 views
Original Research
Published on 21 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 21 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 21 May 2025
in Multiple Sclerosis and Neuroimmunology
Study Protocol
Published on 16 May 2025
in Multiple Sclerosis and Neuroimmunology
Clinical Trial
Published on 09 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 09 May 2025
in Multiple Sclerosis and Neuroimmunology
Correction
Published on 08 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 06 May 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 29 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 28 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 28 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 16 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 15 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 10 Apr 2025
in Multiple Sclerosis and Neuroimmunology